The impact of BNO 1030 on phagocytic activity of white blood cells in rats with type 1 diabetes mellitus
Journal Title: Актуальна інфектологія - Year 2017, Vol 13, Issue 5
Abstract
Background. In the pathogenesis of type 1 diabetes mellitus (DM1) and many of its complications, an important place belongs to a violation of the functional capacity of the immune system, which is the subject of numerous studies. Considering the effectiveness of immunomodulating therapy for DM1 and its complications, one of the most important problems is the search for new effective and harmless immunocorrecting agents with high pharmacological activity. The purpose of this study was to evaluate the effect of the phytopreparation BNO 1030 on the phagocytic activity of blood leukocytes in rats with DM1. Materials and methods. Experimental DM1 in rats was induced by a single intraperitoneal injection of streptozotocin. The percentage of phagocytic cells and macrophage uptake of live fluorescent bacteria in the samples were determined using fluorescent live bacteria Escherichia coli. Results. The effect of the drug BNO 1030 on the phagocytic activity of white blood cells with DM1 in rats was investigated. Under hyperglycemia it was found changes in the redistribution of the main types of leukocytes, namely granulocytes and agranulocytes. The administration of the drug BNO 1030 to both control and diabetic animals resulted in an increase in the number of agranulocytes, which may indicate a modulating effect of the drug on the immune system of animals. Under these conditions, phagocytic activity of leukocytes was decreased as phagocytic number in group of diabetic rats was reduced by 42 % in comparison with group of control animals. BNO 1030 administration to diabetic rats caused an increase of phagocyte number by 24 % compared to the group of diabetic animals. These changes, in turn, are also accompanied by a decrease of phagocytic index as in diabetes, and when drug was administered to experimental groups, indicating disorders in nonspecific cellular immune system. Conclusions. BNO 1030 due to its immunomodulatory effect is effective in the treatment of DM1 and its comorbidity with other chronic diseases.
Authors and Affiliations
Yu. V. Gavrylenko
Keywords
Related Articles
- EP ID EP224871
- DOI 10.22141/2224-0721.13.5.2017.110028
- Views 82
- Downloads 0
On the History of Hospital and Department of Infectious Diseases in Lviv
Hospital of infectious diseases in Lviv was founded on December 29, 1912 and became a clinical basis of the faculty of medicine at Lviv University. At that time, hospital of infectious diseases was a leading medical esta...
Features of management of pregnant women with inflammatory diseases of the thyroid gland and antibody-positive women
The article analyzes new recommendations for the management of pregnant women with inflammatory thyroid diseases, compiled by leading experts of the American Thyroid Association (2017).
Clinical case of a snake bite in a school-age girl
We present a clinical case of a snake bite in 8-year-old girl, who was hospitalized at the intensive care unit of Ternopil Regional Children’s Clinical Hospital. The peculiarity of this case report is the domination of p...
Features of Vitamin D Content in Chronic Viral Hepatitis C
In recent years, the attention of many scientists has been focused on the different aspects of immunomodulatory role of the vitamin D in the human body, and, most of all, its role in the proliferation and differentiation...
Infectious diseases during floods in the world
The article provides a review of scientific literature regarding infectious diseases, increase in the incidence and development of outbreaks associated with floods.